Mechanisms and clinical implications of tumor heterogeneity and convergence on recurrent phenotypes.

McQuerry, Jasmine A; Chang, Jeffrey T; Bowtell, David D L; Cohen, Adam; Bild, Andrea H

McQuerry, Jasmine A; Chang, Jeffrey T; Bowtell, David D L; Cohen, Adam; Bild, Andrea H.

Afiliação

McQuerry JA; Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT, USA.
Chang JT; Department of Oncological Sciences, University of Utah, Salt Lake City, UT, USA.
Bowtell DDL; Department of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, TX, USA.
Cohen A; Peter MacCallum Cancer Centre, Parkville, VIC, Australia.
Bild AH; Sir Peter MacCallum Cancer Centre Department of Oncology, University of Melbourne, Parkville, VIC, Australia.

J Mol Med (Berl) ; 95(11): 1167-1178, 2017 11.

Article em En | MEDLINE | ID: mdl-28871446

Assuntos

Neoplasias/etiologia; Neoplasias/patologia; Animais; Metabolismo Energético; Heterogeneidade Genética; Humanos; Terapia de Alvo Molecular; Neoplasias/metabolismo; Neoplasias/terapia; Fenótipo; Recidiva; Microambiente Tumoral

Palavras-chave

Cancer therapy; Convergent phenotypes; Tumor heterogeneity; Tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google